CardioComm Solutions Stock

CardioComm Solutions Equity

The The Equity of CardioComm Solutions (EKG.V) as of Aug 2, 2026 is -276,600.00 CAD. In the previous year, The Equity was -504,700.00 CAD — a change of -45.20% (higher).

Equity

-276,600.00CAD

YoY

-45.20%

Last updated:

In 2026, CardioComm Solutions's equity was -276,600.00 CAD, a -45.20% increase from the -504,700.00 CAD equity in the previous year.

Access this data via the Eulerpool API

CardioComm Solutions Stock analysis

What does CardioComm Solutions do? CardioComm Solutions Inc is a Canadian company specialized in the development and marketing of monitoring and management solutions for EKG data. The company offers innovative products and services aimed at improving the efficiency and quality of EKG monitoring. History: CardioComm Solutions Inc was founded in 1994 by Etienne Grima in Toronto. Since its establishment, the company has developed a variety of products and services that provide easy and effective access to EKG data. Over the years, CardioComm Solutions Inc has received several awards, including the Innovations Award from Canadian Healthcare Technology in 2008. Business model: CardioComm Solutions Inc's business model includes the development and marketing of EKG monitoring solutions for various markets. The company offers products and services for hospitals, clinics, medical facilities, and other healthcare providers. It also provides solutions for consumer and fitness markets. The company has built an extensive network of partners in North America, Europe, and Asia to provide its customers worldwide with quick and easy access to its products and services. Divisions: CardioComm Solutions Inc offers various divisions. An important focus is on the development of EKG monitoring systems for hospitals and medical facilities. These solutions are aimed at improving workflow and patient monitoring efficiency. Another important area is telemedicine. The company offers solutions that allow patients to monitor their EKG data from home and share it with their doctors. This enables more effective monitoring of patients with heart problems, especially in regions with limited access to medical care. In addition, the company also offers solutions for consumer and fitness markets. One of the company's best-known brands is KardiaMobile. KardiaMobile is a portable EKG device held in the hand and connected to a smartphone app that allows for quick and accurate heart rhythm monitoring. The company has also developed a similar device called KardiaBand, which is worn in the form of a wristband. Products: CardioComm Solutions Inc's products include a variety of EKG monitoring solutions tailored to the needs of different markets. One of the well-known solutions is the Global EKG Management System (GEMS). GEMS is a web-based solution that enables reception, display, and access to EKG data from various locations. The company also offers mobile solutions, including KardiaMobile and KardiaBand, as well as solutions for clinical studies and research projects. Additionally, the company provides training and support for its products and services. Conclusion: CardioComm Solutions Inc is an innovative company that offers a wide range of EKG monitoring and management solutions for various markets. The company has built a reputation for quality and reliability and has a strong presence in the global market. With its advanced technology and dedicated professionals, CardioComm Solutions Inc is well-positioned to achieve further growth and success in the coming years. CardioComm Solutions is one of the most popular companies on Eulerpool.

Equity Details

Analyzing CardioComm Solutions's Equity

CardioComm Solutions's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding CardioComm Solutions's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating CardioComm Solutions's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

CardioComm Solutions's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in CardioComm Solutions’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about CardioComm Solutions stock

The Equity of CardioComm Solutions is -276,600.00 CAD in 2026.

Access this data via the Eulerpool API

Balance Sheet — CardioComm Solutions

All Key Metrics — CardioComm Solutions